INSIGHTS ON CLINICAL TRIAL DESIGN
-
The Hidden Complexity Of Ophthalmic Protocol Requirements
Explore the critical role of meticulously planning ophthalmic assessments in clinical trials, highlighting their potential risks and complexities.
-
Transforming Effective Patient Recruitment Within The Changing Health Care Landscape
Revolutionize patient enrollment by closing the "95% gap." Explore an approach that uses digital health and data-driven insights to engage diverse populations where they live.
-
Master Protocols: Implementing Effective Treatment Adaptations
From balancing treatment ratios and managing eligibility to accommodating site-specific readiness and protocol amendments, a well-designed IRT system enables seamless transitions.
-
Protocol Design Choices That Trigger IRB And Regulatory Requirements
Learn how protocol choices like AI, adaptive designs, and decentralized methods impact IRB review, participant protections, consent, and key regulatory requirements in clinical research.
-
Understanding The FDA's Push For More Representation In Clinical Trials1/28/2025
Take action to improve diversity in clinical trials by addressing underrepresentation and ensuring equitable access to medical interventions, as emphasized by the FDA’s new 2025 guidance.
-
How Mobile Clinics Advance Diversity In Clinical Research12/4/2025
Mobile clinics reduce participation barriers, enable more inclusive trials, deliver representative data, speed timelines, and advance equity in research.
-
Digital Transformation As A Foundation For Modern Chronic Disease Trials6/16/2026
Site-centric chronic trials cause patient burden. Learn how wearables and a decentralized model can shift research to continuous data capture, removing travel barriers to improve retention and disease tracking.
-
Breaking Silos In Drug Development: The Power Of An Integrated Model5/11/2026
Experts share how Altasciences' integrated Preclinical/Clinical model results in fewer handoffs, greater continuity, and accelerated progress from the nonclinical phase to first-in-human trials.
-
Virtual eConsent For Decentralized Trials12/23/2025
Virtual eConsent improves accessibility and compliance in decentralized trials, streamlining enrollment with a secure, user-friendly process for informed consent in remote research.
CLINICAL TRIAL DESIGN SOLUTIONS
-
With three clinical pharmacology units, access to 145,000+ hepatic/renal patients, and 100+ completed studies, we’re your partner for NDA-enabling trials.
-
Simplify biosafety oversight and accelerate study startup with expert guidance that ensures NIH compliance while protecting researchers, communities, and the environment.
-
By combining proactive safety measures, personalized support, and reliable logistics, the Safe-to-Site Initiative enhances the clinical trial experience by removing the challenges of participation.
-
Advancing a novel therapy through clinical development is complicated. Not all therapies make it to the patients that need them.
-
Whether used for routine appointments or trial participation, Lyft Pass ensures that patients have timely access to transportation, supporting adherence to schedules and improving overall engagement.